65.82
Genedx Holdings Corp stock is traded at $65.82, with a volume of 216.28K.
It is down -0.84% in the last 24 hours and up +8.02% over the past month.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
See More
Previous Close:
$66.37
Open:
$64.68
24h Volume:
216.28K
Relative Volume:
0.21
Market Cap:
$1.97B
Revenue:
$267.23M
Net Income/Loss:
$-83.50M
P/E Ratio:
-21.16
EPS:
-3.11
Net Cash Flow:
$-59.99M
1W Performance:
-8.68%
1M Performance:
+8.02%
6M Performance:
-12.75%
1Y Performance:
+128.76%
Genedx Holdings Corp Stock (WGS) Company Profile
Name
Genedx Holdings Corp
Sector
Industry
Phone
888-729-1206
Address
333 LUDLOW STREET, STAMFORD
Compare WGS with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
WGS
Genedx Holdings Corp
|
65.84 | 1.97B | 267.23M | -83.50M | -59.99M | -3.11 |
![]()
TMO
Thermo Fisher Scientific Inc
|
410.72 | 150.38B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
204.11 | 137.52B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
525.32 | 42.00B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
118.54 | 32.37B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
158.70 | 25.50B | 15.50B | 1.33B | 2.16B | 7.34 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
May-15-25 | Initiated | Guggenheim | Buy |
May-09-25 | Upgrade | Jefferies | Hold → Buy |
Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
Jul-10-24 | Initiated | Craig Hallum | Buy |
Jun-03-24 | Resumed | Jefferies | Hold |
Genedx Holdings Corp Stock (WGS) Latest News
WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Fraud Investigation with the Schall Law Firm - The Malaysian Reserve
Rosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation – WGS - The Joplin Globe
GeneDx Holdings Corp. Executives Sell Shares for Tax Obligations - TradingView
Transcript : GeneDx Holdings Corp. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 04 - marketscreener.com
GeneDx at Goldman Sachs Conference: Strategic Focus on Rare Disease Diagnostics - Investing.com Nigeria
How To Trade (WGS) - news.stocktradersdaily.com
GeneDx at Jefferies Global Healthcare: Driving Growth in Rare Disease Testing By Investing.com - Investing.com South Africa
GeneDx at Jefferies Global Healthcare: Driving Growth in Rare Disease Testing - Investing.com Australia
Bank of America Corp DE Lowers Position in GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
GeneDx Holdings Corp (WGS) Shares Up 3.86% on Jun 2 - GuruFocus
Millennium Management LLC Trims Stock Holdings in GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
GeneDx Holdings Corp. (NASDAQ:WGSWW) Sees Significant Growth in Short Interest - Defense World
Wall Street Analysts Predict a 32.62% Upside in GENEDX HOLDINGS (WGS): Here's What You Should Know - MSN
GeneDx Holdings Corp. (NASDAQ:WGS) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $552,000 Stock Holdings in GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
Possible Bearish Signals With GeneDx Holdings Insiders Disposing Stock - simplywall.st
Ameriprise Financial Inc. Acquires New Position in GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
Deutsche Bank AG Sells 113,731 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
Here's Why You Should Add Pediatrix Medical to Your Portfolio Now - The Globe and Mail
GeneDx Holdings Corp. (WGS) Stock Analysis: A Strong 30% Upside Potential Beckons Investors - DirectorsTalk Interviews
Lazard Asset Management LLC Invests $35,000 in GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
(WGS) Long Term Investment Analysis - news.stocktradersdaily.com
Nuveen Asset Management LLC Raises Stock Holdings in GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
GeneDx to Participate in Upcoming Investor Conferences - Business Wire
GeneDx Publishes Pioneering Vision for Applying AI to Genomics to Improve and Expedite Diagnosis of Genetic Disease at Scale - Business Wire
GeneDx: Strong Fundamentals Intact As Market Misreads Test Volume Dip - Seeking Alpha
Comerica Bank Makes New $50,000 Investment in GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
GeneDx (NASDAQ:WGS) Trading Up 5.8% – Here’s What Happened - Defense World
Guggenheim Begins Coverage on GeneDx (NASDAQ:WGS) - Defense World
GeneDx Holdings Corp (WGS) Shares Up 6.43% on May 16 - GuruFocus
How the (WGS) price action is used to our Advantage - news.stocktradersdaily.com
GeneDx (WGS) Receives Positive Outlook from Guggenheim with Buy Rating | WGS Stock News - GuruFocus
Guggenheim Initiates GeneDx Holdings at Buy With $88 Price Target - marketscreener.com
GeneDx shares tumble 40% after InvestingPro's overvaluation alert By Investing.com - Investing.com South Africa
GeneDx shares tumble 40% after InvestingPro’s overvaluation alert By Investing.com - Investing.com Canada
GeneDx upgraded to Buy from Hold on growth outlook - MSN
GeneDx: Time To Buy The Dip (NASDAQ:WGS) - Seeking Alpha
GeneDx plunges despite Q1 beat and guidance raise - MSN
Voya Investment Management LLC Invests $292,000 in GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
GeneDx Holdings stock trades higher as upgraded at Jefferies - MSN
WGS: Key Meeting Announcement by BTIG in San Francisco | WGS Sto - GuruFocus
WGS: Key Meeting Announcement by BTIG in San Francisco | WGS Stock News - GuruFocus
GeneDx (NASDAQ:WGS) Stock Rating Upgraded by Jefferies Financial Group - Defense World
GeneDx Shares Rise After Ratings Upgrade From Jefferies - marketscreener.com
GeneDx Holdings (WGS) Upgraded by Jefferies on Growth Prospects - GuruFocus
GeneDx (WGS) Upgraded by Jefferies Amid Growth Prospects - GuruFocus
GeneDx stock upgraded at Jefferies on outlook (WGS:NASDAQ) - Seeking Alpha
Genedx Holdings Corp Stock (WGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Genedx Holdings Corp Stock (WGS) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Feeley Kevin | CHIEF FINANCIAL OFFICER |
Jun 09 '25 |
Sale |
72.55 |
1,266 |
91,848 |
5,301 |
Stueland Katherine | Chief Executive Officer |
Jun 09 '25 |
Option Exercise |
0.00 |
6,547 |
0 |
9,987 |
Stueland Katherine | Chief Executive Officer |
Jun 09 '25 |
Sale |
72.55 |
3,639 |
264,009 |
6,348 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):